A Study to Evaluate Efficacy and Safety of Denosumab for Prevention and Treatment of Osteoporosis in 1st Time Liver Transplant Recipients.

PHASE2WithdrawnINTERVENTIONAL

Timeline

Start Date

July 1, 2020

Primary Completion Date

January 1, 2024

Study Completion Date

January 1, 2025

Conditions

Osteoporosis

Interventions

DRUG

Denosumab Injection

Use of denosumab in post liver transplant patient for prevention and management of osteoporosis and bone loss.

DRUG

Placebos

Use of placebo in post liver transplant patient for prevention and management of osteoporosis and bone loss.